Remium-F Tablets offer a premium, clinically integrated combination therapy carefully engineered for the management of mixed dyslipidemia and hypertriglyceridemia in adult patients. By pairing two distinct yet complementary classes of lipid-modifying compounds into a single daily unit, this medication efficiently controls complex lipid abnormalities where single-statin options fail to satisfy target triglyceride thresholds.
The first component, Rosuvastatin, acts as a potent HMG-CoA reductase inhibitor (statin). It targets cholesterol production within the liver, causing an uptick in surface hepatic LDL receptors that rapidly capture and break down circulating low-density lipoprotein (“bad” cholesterol) from the bloodstream. The second component, Fenofibrate, is a fibric acid derivative that acts as an agonist for the Peroxisome Proliferator-Activated Receptor Alpha (PPAR-alpha). Activating PPAR-alpha accelerates the extraction and clearance of triglyceride-rich particles from the plasma by activating lipoprotein lipase and reducing the liver’s synthesis of VLDL. Together, Remium-F systematically scales down structural arterial plaque development (atherosclerosis), safeguards vascular flexibility, and shields the patient from major cardiac complications.
Key Benefits
-
Dual-Target Lipid Control: Simultaneously lowers severe bad cholesterol (LDL) and high fat layers (triglycerides) in a single step.
-
Aggressive Triglyceride Clearing: Fenofibrate maximizes natural enzyme activity to empty complex fatty blocks out of circulation.
-
Raises Good Cholesterol: Effectively boosts protective HDL parameters to promote long-term arterial wellness.
-
Streamlined Adherence: Replaces complex multi-pill schedules with one optimized, daily combination tablet to prevent pill fatigue.
-
Trusted Quality: Manufactured under the strict pharmaceutical quality standards of Daxia Healthcare to guarantee uniform dosing bio-availability.
Directions for Use
-
Take exactly as directed by your physician or cardiologist.
-
Swallow the tablet whole with a full glass of water. Do not crush, break, or chew it.
-
Remium-F is highly recommended to be taken alongside or immediately after a main meal because food significantly enhances the structural absorption and bioavailability of the fenofibrate component.
-
Maintain consistency by executing your dose at the exact same time every single day, preferably with your evening meal.
Safety & Precautions
-
Do not stop taking this medication suddenly. Halting lipid therapies can cause cholesterol and triglyceride arrays to bounce back sharply, placing renewed stress on the blood vessels.
-
Inform your specialist immediately if you experience unexplained muscle pain, tenderness, or weakness—especially if accompanied by a fever or general lethargy—as combining statins with fibrates requires careful observation for potential muscle tissue health impacts (myopathy/rhabdomyolysis).
-
Contraindicated during pregnancy and breastfeeding: This medication can cause serious structural harm or developmental injury to a developing fetus. If pregnancy is detected or planned, stop the routine immediately and seek professional advice.
-
Contraindicated for individuals with active liver diseases, severe gallbladder disease, severe kidney impairment, or unexplained elevations in liver transaminases. Periodic liver function tests (LFTs) and kidney profiles are highly recommended.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight, excessive heat, and environmental room moisture.
-
Keep the tablets safely stored inside their original protective packaging until the time of consumption.
